KB
Kobayashi Pharmaceutical Co., Ltd.
KBYPF · OTC
$34.05 +0.00% (+$0.00)
Market Cap ¥397.4B
P/E Ratio 236.28x
Div. Yield 1.98%
ROE 0.80%
Bulios Fair Price
$19.53
42.6% downside
Current Price
$34.05
Undervalued Fair Value Overvalued
According to Bulios Fair Price, KBYPF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
45 /100
Fair P/E 236.28x
P/B 1.91x
EV/EBITDA 16.41x
Growth
13 /100
Declining EPS growth 42.79%
Book val. growth 2.19%
Rev. growth 0.07%
Profitability
31 /100
Weak Gross margin 49.85%
FCF margin 2.88%
Net margin 1.00%
Quality
17 /100
Poor ROIC 5.23%
Asset turnover 0.67x
ROE 0.80%
Debt
100 /100
Low Debt/Equity 0.00x
Net debt/EBITDA -2.35x
Current ratio 3.28x
Stability
75 /100
Stable Beta 0.25x
Profitable years 6
Rev. volatility 4.43%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about KBYPF
Online
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Norikazu Toyoda
Employees
3,731
Headquarters
Osaka
Upcoming events
05 NOV
Earnings
Upcoming earnings report
31 DEC
Ex-Dividend
Ex-dividend date